HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 68 filers reported holding NEOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$62,000
+17.0%
100,0000.0%0.02%0.0%
Q3 2020$53,000
-23.2%
100,0000.0%0.02%
-28.6%
Q2 2020$69,000
-8.0%
100,0000.0%0.02%
-27.6%
Q1 2020$75,000
-50.3%
100,0000.0%0.03%
-38.3%
Q4 2019$151,000
-67.0%
100,000
+100.0%
0.05%
-73.6%
Q3 2017$457,000
+25.2%
50,0000.0%0.18%
+20.3%
Q2 2017$365,000
+1.4%
50,0000.0%0.15%
-2.0%
Q1 2017$360,00050,0000.15%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders